Class IIIOngoingVoluntary: Firm initiated
Kosher First LLC: food recall H-0238-2026
Kosher First LLC of Brooklyn, NY recalled Shloimy's Heimishe Matjes Herring packaged in 7oz plastic container. Reason: Undeclared FD&C Red #40. The FDA listed it as Class III in its Enforcement Report dated Dec 17, 2025; distribution: New York.
Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Shloimy's Heimishe Matjes Herring packaged in 7oz plastic container
- Product quantity
- 283 units
- Reason for recall
- Undeclared FD&C Red #40
- Codes, lots and dates on the package
- Batch Code: 0103
- Distribution pattern
- New York
- Recalling firm
- Kosher First LLC, Brooklyn, NY
- Classification
- Class III — the FDA uses this class for a situation in which using or being exposed to the product is not likely to cause adverse health consequences.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Letter
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Nov 10, 2025 |
| Classified by the FDA | Dec 5, 2025 |
| Published in the Enforcement Report | Dec 17, 2025 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0238-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.